CLX
Clorox
$90.60
▼ 5.4%Updated Today 7:15 PM ET
▼ Down 20.8% over the last 12 months
Market Cap
$11.58B
P/E
15.31x
Forward P/E (est.)
13.84x
ROE
453.7%
Revenue Growth
-3.7%
EPS Growth
10.6%
Profit Margin
11.2%
FCF Yield
2.8%
Debt / Equity
7.86x
ROIC
—
Interest Coverage
—
Current Ratio
0.84x
Dividend Yield
5.2%
Implied Growth (rev. DCF)
2.3%
Rating Score
44/100
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what CLX's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. CLX trades near $90.60, below its 50-day average ($95.37) and 200-day average ($108.12). Price below both averages is a downtrend — momentum is against buyers for now.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 63 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. CLX's is $2.80 (~3.1% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month CLX found buyers near $87.91 (support) and sellers near $100.73 (resistance); its 52-week range is $84.70–$132.03. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 1.8× the 20-day average — heavier than usual, which adds conviction to the move. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
Clorox (CLX) is a large-cap company in the Household Products industry, part of the Consumer Staples sector of the S&P 500, with a market value around $11.58B.
In its latest reported year it generated about $7.10B in revenue and $810.00M in net profit.
Our model rates CLX Neutral (44/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
4Y CAGR
-0.8%
Revenue moved from $7.34B in 2021 to $7.10B in 2025, a -0.8% compound annual growth rate. The most recent year declined 3.7% year over year. Shrinking revenue is worth a closer look — is it cyclical or structural?
Gross Margin
45.2%
Operating Margin
14.6%
Net Margin
11.4%
ROE
453.7%
Clorox keeps about 11.2% of each sales dollar as net profit, with a 45.2% gross margin and 14.6% operating margin. Return on equity is 453.7%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$2.48B
Net Debt
$1.30B
Net Debt / EBITDA
—
Debt / Equity
7.86x
Leverage: debt-to-equity is 7.9x, with a current ratio of 0.8x. That is elevated leverage, which raises risk if earnings or rates move against it. It carries roughly $2.48B of total debt against $1.19B of cash.
Operating CF
$981.00M
Free Cash Flow
$761.00M
FCF Margin
10.7%
In the latest year Clorox produced about $981.00M of operating cash flow and $761.00M of free cash flow after capital spending. That is a free-cash-flow yield of about 2.8% on today's price. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
P/E
15.31x
P/S
1.66x
P/B
45.29x
EV / EBITDA
—
CLX trades at 15.3x trailing earnings (about 13.8x on estimated forward earnings), 1.7x sales, and 45.3x book value. Reverse-engineering today's price implies the market expects roughly 2.3% long-term free-cash-flow growth. That is a fairly typical valuation for a profitable company.
Where this stock sits versus what most companies trade at.
Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.
How CLX stacks up against its Consumer Staples peers — valuation, profitability, and growth versus the sector median.
In the Consumer Staples sector (36 S&P 500 companies), CLX ranks #21 of 36 by our overall rating. It trades at a discount versus the sector on earnings (15.3x P/E vs. 22.5x median) with a higher return on equity (453.7% vs. 20.2%) and slower revenue growth (-3.7% vs. 3.0%).
P/E vs sector
15.3x
median 22.5x
ROE vs sector
453.7%
median 20.2%
Growth vs sector
-3.7%
median 3.0%
Sector rank
#21
of 36 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Consumer Staples companies by sub-industry and size. Sector median is across all 36 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$67.43 – $112.38
vs. $90.60 today · expected CAGR -6% – 4%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $7.32B | $7.54B | $7.76B | $8.00B | $8.24B |
| Net income | $804.88M | $829.03M | $853.90M | $879.52M | $905.90M |
| EPS | $6.66 | $6.86 | $7.06 | $7.27 | $7.49 |
| Share price (low) | $59.91 | $61.70 | $63.55 | $65.46 | $67.43 |
| Share price (high) | $99.84 | $102.84 | $105.92 | $109.10 | $112.38 |
| CAGR (low–high) | -34% / 10% | -17% / 7% | -11% / 5% | -8% / 5% | -6% / 4% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for CLX:
- Strong return on equity (453.7%) shows capital is put to work well.
- Pays a 5.2% dividend on top of any price gains.
The case against CLX:
- Revenue growth is slow/negative (-3.7%), limiting the upside engine.
- Elevated leverage (debt/equity 7.9x) adds financial risk.
Balance-sheet risk — debt/equity of 7.9x magnifies the impact of higher rates or weaker earnings.
Growth risk — sluggish revenue (-3.7%) leaves little margin for execution missteps.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Clorox is a large-cap consumer staples business with shrinking revenue, with modest profitability, and a heavier debt load to watch. It trades at 15.3x earnings, which our model scores Neutral (44/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.